Flputnam Investment Management Co. Sells 1,658 Shares of Sanofi (NASDAQ:SNY)

Flputnam Investment Management Co. decreased its holdings in shares of Sanofi (NASDAQ:SNY) by 24.5% in the fourth quarter, Holdings Channel.com reports. The firm owned 5,109 shares of the company’s stock after selling 1,658 shares during the period. Flputnam Investment Management Co.’s holdings in Sanofi were worth $246,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the business. Synergy Asset Management LLC bought a new position in Sanofi during the 4th quarter valued at approximately $25,000. McClarren Financial Advisors Inc. grew its stake in shares of Sanofi by 952.6% in the fourth quarter. McClarren Financial Advisors Inc. now owns 600 shares of the company’s stock worth $28,000 after acquiring an additional 543 shares during the last quarter. Sunbelt Securities Inc. increased its holdings in shares of Sanofi by 72.1% during the third quarter. Sunbelt Securities Inc. now owns 747 shares of the company’s stock valued at $43,000 after acquiring an additional 313 shares in the last quarter. Sierra Ocean LLC purchased a new position in shares of Sanofi in the 4th quarter worth about $44,000. Finally, Versant Capital Management Inc bought a new position in Sanofi in the 4th quarter worth about $54,000. 14.04% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms have weighed in on SNY. StockNews.com lowered shares of Sanofi from a “buy” rating to a “hold” rating in a research note on Thursday, December 12th. Deutsche Bank Aktiengesellschaft raised shares of Sanofi from a “sell” rating to a “hold” rating in a research report on Thursday, January 30th. Finally, Sanford C. Bernstein upgraded shares of Sanofi to a “strong-buy” rating in a report on Thursday, January 30th. Two analysts have rated the stock with a hold rating, one has given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and an average price target of $60.00.

Sanofi Stock Performance

SNY stock opened at $56.52 on Tuesday. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.46 and a quick ratio of 1.14. Sanofi has a 1 year low of $45.22 and a 1 year high of $58.97. The company has a market cap of $143.44 billion, a P/E ratio of 22.70, a price-to-earnings-growth ratio of 1.01 and a beta of 0.57. The stock’s fifty day moving average price is $51.81 and its 200-day moving average price is $52.61.

Sanofi (NASDAQ:SNY) last announced its earnings results on Thursday, January 30th. The company reported $0.70 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.70. Sanofi had a net margin of 12.77% and a return on equity of 25.61%. On average, equities analysts forecast that Sanofi will post 4.36 earnings per share for the current year.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.